Incidental Mutation 'IGL00766:Plau'
ID 13032
Institutional Source Australian Phenomics Network (link to record)
Gene Symbol Plau
Ensembl Gene ENSMUSG00000021822
Gene Name plasminogen activator, urokinase
Synonyms u-PA, uPA, urokinase-type plasminogen activator
Accession Numbers
Essential gene? Non essential (E-score: 0.000) question?
Stock # IGL00766
Quality Score
Status
Chromosome 14
Chromosomal Location 20886728-20893453 bp(+) (GRCm39)
Type of Mutation missense
DNA Base Change (assembly) A to G at 20888635 bp (GRCm39)
Zygosity Heterozygous
Amino Acid Change Asparagine to Serine at position 84 (N84S)
Ref Sequence ENSEMBL: ENSMUSP00000022368 (fasta)
Gene Model predicted gene model for transcript(s): [ENSMUST00000022368] [ENSMUST00000224141]
AlphaFold P06869
PDB Structure Structure-based engineering of species selectivity in the uPA-uPAR interaction [X-RAY DIFFRACTION]
Predicted Effect probably benign
Transcript: ENSMUST00000022368
AA Change: N84S

PolyPhen 2 Score 0.045 (Sensitivity: 0.94; Specificity: 0.83)
SMART Domains Protein: ENSMUSP00000022368
Gene: ENSMUSG00000021822
AA Change: N84S

DomainStartEndE-ValueType
EGF 10 64 3.23e0 SMART
KR 69 154 3.2e-36 SMART
Tryp_SPc 179 421 3.53e-84 SMART
Predicted Effect probably benign
Transcript: ENSMUST00000224141
Coding Region Coverage
Validation Efficiency
MGI Phenotype FUNCTION: [Summary is not available for the mouse gene. This summary is for the human ortholog.] This gene encodes a secreted serine protease that converts plasminogen to plasmin. The encoded preproprotein is proteolytically processed to generate A and B polypeptide chains. These chains associate via a single disulfide bond to form the catalytically inactive high molecular weight urokinase-type plasminogen activator (HMW-uPA). HMW-uPA can be further processed into the catalytically active low molecular weight urokinase-type plasminogen activator (LMW-uPA). This low molecular weight form does not bind to the urokinase-type plasminogen activator receptor. Mutations in this gene may be associated with Quebec platelet disorder and late-onset Alzheimer's disease. Alternative splicing results in multiple transcript variants, at least one of which encodes an isoform that is proteolytically processed. [provided by RefSeq, Jan 2016]
PHENOTYPE: Homozygotes show occasional fibrin deposits in non-healing ulcerations and reduced neointima formation after arterial injury. They are susceptible to thrombosis after traumatic or inflammatory challenge and appear to be immunologically hyporesponsive displaying characteristics of functional anergy. [provided by MGI curators]
Allele List at MGI
Other mutations in this stock
Total: 34 list
GeneRefVarChr/LocMutationPredicted EffectZygosity
Adgrl3 T A 5: 81,942,415 (GRCm39) D1379E probably damaging Het
Akap13 A G 7: 75,354,260 (GRCm39) T1794A probably damaging Het
Ano2 A T 6: 125,990,216 (GRCm39) D779V probably damaging Het
Ap3b1 G T 13: 94,679,392 (GRCm39) probably benign Het
Arfgef1 A G 1: 10,270,012 (GRCm39) V379A probably benign Het
Arhgef10 A G 8: 15,025,006 (GRCm39) Y398C probably damaging Het
Arid2 C T 15: 96,268,286 (GRCm39) R800C probably benign Het
Ccdc88a T A 11: 29,451,046 (GRCm39) H306Q probably damaging Het
Cckar C A 5: 53,857,378 (GRCm39) R344L probably damaging Het
Cplane1 A T 15: 8,281,648 (GRCm39) Q2829L unknown Het
Egfem1 A G 3: 29,711,302 (GRCm39) I237V possibly damaging Het
Erlec1 T A 11: 30,900,623 (GRCm39) K143* probably null Het
Glyat T G 19: 12,628,626 (GRCm39) D140E probably benign Het
Grhl2 T C 15: 37,336,545 (GRCm39) F50L probably damaging Het
Havcr2 T C 11: 46,360,373 (GRCm39) V151A probably damaging Het
Herc1 A G 9: 66,358,023 (GRCm39) Y2368C probably damaging Het
Ift80 A T 3: 68,821,986 (GRCm39) Y686* probably null Het
Itga7 G T 10: 128,777,723 (GRCm39) D235Y possibly damaging Het
Kctd3 C T 1: 188,727,973 (GRCm39) V199I probably benign Het
Mettl25 A G 10: 105,615,443 (GRCm39) probably benign Het
Myoz2 G A 3: 122,810,193 (GRCm39) probably benign Het
Nepro C T 16: 44,549,668 (GRCm39) Q43* probably null Het
Ophn1 T C X: 97,846,720 (GRCm39) D74G probably damaging Het
Rprd2 A G 3: 95,672,691 (GRCm39) V904A possibly damaging Het
Satl1 T C X: 111,315,466 (GRCm39) K330E possibly damaging Het
Sis C T 3: 72,814,570 (GRCm39) probably benign Het
Slc5a5 A C 8: 71,341,181 (GRCm39) I386S probably damaging Het
Slco1c1 T C 6: 141,493,609 (GRCm39) Y264H probably damaging Het
Sulf1 A C 1: 12,890,687 (GRCm39) D375A probably damaging Het
Tesl1 C A X: 23,772,838 (GRCm39) A113E probably benign Het
Tgfbi A G 13: 56,778,408 (GRCm39) D393G probably benign Het
Trim59 A C 3: 68,944,712 (GRCm39) D209E probably benign Het
Ubqln3 G T 7: 103,792,031 (GRCm39) Q20K probably benign Het
Ubr4 A G 4: 139,168,077 (GRCm39) D2808G probably damaging Het
Other mutations in Plau
AlleleSourceChrCoordTypePredicted EffectPPH Score
IGL01831:Plau APN 14 20,887,838 (GRCm39) splice site probably benign
IGL02902:Plau APN 14 20,889,965 (GRCm39) missense possibly damaging 0.63
R0426:Plau UTSW 14 20,892,382 (GRCm39) missense probably benign 0.23
R2006:Plau UTSW 14 20,888,760 (GRCm39) splice site probably null
R2357:Plau UTSW 14 20,888,683 (GRCm39) missense probably damaging 1.00
R4089:Plau UTSW 14 20,891,134 (GRCm39) missense probably damaging 1.00
R4866:Plau UTSW 14 20,887,872 (GRCm39) missense probably benign 0.05
R6737:Plau UTSW 14 20,887,884 (GRCm39) missense probably damaging 0.98
R7167:Plau UTSW 14 20,889,518 (GRCm39) missense possibly damaging 0.90
R7615:Plau UTSW 14 20,889,534 (GRCm39) nonsense probably null
R7687:Plau UTSW 14 20,889,866 (GRCm39) missense probably damaging 1.00
R7775:Plau UTSW 14 20,892,393 (GRCm39) missense probably benign 0.16
R7824:Plau UTSW 14 20,892,393 (GRCm39) missense probably benign 0.16
R8200:Plau UTSW 14 20,889,181 (GRCm39) missense possibly damaging 0.53
R8685:Plau UTSW 14 20,889,627 (GRCm39) splice site probably benign
R9007:Plau UTSW 14 20,889,613 (GRCm39) missense probably damaging 1.00
R9077:Plau UTSW 14 20,889,949 (GRCm39) missense probably benign 0.09
Z1176:Plau UTSW 14 20,889,549 (GRCm39) missense probably damaging 1.00
Z1177:Plau UTSW 14 20,891,082 (GRCm39) nonsense probably null
Posted On 2012-12-06